Didier Morel

580 total citations
23 papers, 417 citations indexed

About

Didier Morel is a scholar working on Emergency Medicine, Neurology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Didier Morel has authored 23 papers receiving a total of 417 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Emergency Medicine, 7 papers in Neurology and 7 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Didier Morel's work include Intramuscular injections and effects (8 papers), Botulinum Toxin and Related Neurological Disorders (7 papers) and Diabetes Management and Research (7 papers). Didier Morel is often cited by papers focused on Intramuscular injections and effects (8 papers), Botulinum Toxin and Related Neurological Disorders (7 papers) and Diabetes Management and Research (7 papers). Didier Morel collaborates with scholars based in United States, Switzerland and India. Didier Morel's co-authors include Laurence Hirsch, Kenneth Strauss, Anders Frid, Ronald J. Pettis, G Brugal, Gilbert Bigras, Ying P. Tabak, Diane Sutter, Gilbert Greub and Antony Croxatto and has published in prestigious journals such as Cancer Research, Diabetes and Journal of Clinical Microbiology.

In The Last Decade

Didier Morel

21 papers receiving 389 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Didier Morel United States 11 205 81 79 49 47 23 417
Jonas Kildegaard Denmark 11 187 0.9× 67 0.8× 55 0.7× 46 0.9× 49 1.0× 20 380
Nancy Wei United States 13 162 0.8× 42 0.5× 10 0.1× 87 1.8× 22 0.5× 20 465
Braulio A. Marfil‐Garza Canada 14 137 0.7× 175 2.2× 12 0.2× 114 2.3× 17 0.4× 42 523
Sichao Chen China 12 82 0.4× 28 0.3× 158 2.0× 72 1.5× 5 0.1× 32 470
Guangzhen He China 7 75 0.4× 90 1.1× 117 1.5× 90 1.8× 5 0.1× 11 445
Zuzanna Drebert Belgium 9 69 0.3× 37 0.5× 22 0.3× 94 1.9× 3 0.1× 17 427
Xingzhong Hu China 8 19 0.1× 38 0.5× 134 1.7× 73 1.5× 10 0.2× 15 522
D. Pei United States 9 27 0.1× 28 0.3× 16 0.2× 62 1.3× 7 0.1× 12 483
Chris Van Schravendijk Belgium 14 209 1.0× 111 1.4× 12 0.2× 88 1.8× 4 0.1× 23 439
Neil Reynolds United Kingdom 10 43 0.2× 18 0.2× 35 0.4× 55 1.1× 11 0.2× 15 352

Countries citing papers authored by Didier Morel

Since Specialization
Citations

This map shows the geographic impact of Didier Morel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Didier Morel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Didier Morel more than expected).

Fields of papers citing papers by Didier Morel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Didier Morel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Didier Morel. The network helps show where Didier Morel may publish in the future.

Co-authorship network of co-authors of Didier Morel

This figure shows the co-authorship network connecting the top 25 collaborators of Didier Morel. A scholar is included among the top collaborators of Didier Morel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Didier Morel. Didier Morel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McElvania, Erin, Parul Patel, Caryn E. Good, et al.. (2024). Automated detection of methicillin-resistant Staphylococcus aureus with the MRSA CHROM imaging application on BD Kiestra Total Lab Automation System. Journal of Clinical Microbiology. 62(5). e0144523–e0144523. 6 indexed citations
2.
Roberts, Bruce C., et al.. (2021). Novel cannula design improves large volume auto-injection rates for high viscosity solutions. Drug Delivery. 29(1). 43–51. 3 indexed citations
3.
Morel, Didier, et al.. (2021). Clinical evaluation of large volume subcutaneous injection tissue effects, pain, and acceptability in healthy adults. Clinical and Translational Science. 15(1). 92–104. 27 indexed citations
4.
Morel, Didier, et al.. (2020). Predicting hospital readmission in patients with mental or substance use disorders: A machine learning approach. International Journal of Medical Informatics. 139. 104136–104136. 30 indexed citations
5.
Barnard‐Kelly, Katharine, et al.. (2020). Injection Technique: Development of a Novel Questionnaire and User Guide. Diabetes Spectrum. 34(2). 156–165. 3 indexed citations
6.
Morel, Didier, et al.. (2020). Clinical Evaluation of an Investigational 5 mL Wearable Injector in Healthy Human Subjects. Clinical and Translational Science. 14(3). 859–869. 15 indexed citations
7.
Bostick, David, et al.. (2020). 210. Vancomycin Infusion Frequency and Intensity: Analysis of Real-World Data Generated from Automated Infusion Devices. Open Forum Infectious Diseases. 7(Supplement_1). S108–S108.
8.
Roberts, Bruce C., et al.. (2019). Evaluating the Impact of Human Factors and Pen Needle Design on Insulin Pen Injection. Journal of Diabetes Science and Technology. 13(3). 533–545. 15 indexed citations
9.
Roberts, Bruce C., et al.. (2018). Evaluating Human Factors and Design Variables on Pen Injection Technique. Diabetes. 67(Supplement_1). 1 indexed citations
10.
Morel, Didier, et al.. (2018). Impact of Continuous Glucose Monitors’ Accuracy on Their Clinical Utility—A Quantitative Assessment. Diabetes. 67(Supplement_1). 1 indexed citations
11.
Croxatto, Antony, et al.. (2017). Towards automated detection, semi-quantification and identification of microbial growth in clinical bacteriology: A proof of concept. Biomedical Journal. 40(6). 317–328. 29 indexed citations
12.
Floch, Jean‐Pierre Le, Catherine Petit, Alfred Penfornis, et al.. (2017). An Effective Intervention for Diabetic Lipohypertrophy: Results of a Randomized, Controlled, Prospective Multicenter Study in France. Diabetes Technology & Therapeutics. 19(11). 623–632. 35 indexed citations
13.
Frid, Anders, et al.. (2016). Worldwide Injection Technique Questionnaire Study. Mayo Clinic Proceedings. 91(9). 1224–1230. 93 indexed citations
14.
Frid, Anders, et al.. (2016). Worldwide Injection Technique Questionnaire Study. Mayo Clinic Proceedings. 91(9). 1212–1223. 85 indexed citations
15.
Bigras, Gilbert, et al.. (2016). New MYC IHC Classifier Integrating Quantitative Architecture Parameters to Predict MYC Gene Translocation in Diffuse Large B-Cell Lymphoma. Applied immunohistochemistry & molecular morphology. 26(1). 54–63. 4 indexed citations
17.
Morel, Didier, et al.. (2011). [Functional insulin therapy courses adapted to the patient's reality].. PubMed. 7(298). 1255–6, 1258. 1 indexed citations
19.
Whitehead, Clark M., et al.. (2005). Overexpression of the PSMB9 component of the proteasome in early stage, node negative breast cancer is prognostic for an increased risk of early relapse or death. Cancer Research. 65. 740–740. 2 indexed citations
20.
Morel, Didier, et al.. (2001). A Proliferation Control Network Model: The Simulation of Two-Dimensional Epithelial Homeostasis. Acta Biotheoretica. 49(4). 219–234. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026